Vanda Pharmaceuticals
VNDA
#8548
Rank
โ‚น26.72 B
Marketcap
โ‚น442.06
Share price
0.88%
Change (1 day)
-8.59%
Change (1 year)

Vanda Pharmaceuticals (VNDA) - Total liabilities

Total liabilities on the balance sheet as of June 2026 : โ‚น18.59 Billion

According to Vanda Pharmaceuticals's latest financial reports the company's total liabilities are โ‚น18.59 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Vanda Pharmaceuticals - Total liabilities on balance sheet (from 2005 to 2026)

Total liabilities by year

Year Total liabilities Change
2025-12-31โ‚น14.52 B43.87%
2024-12-31โ‚น10.09 B17.11%
2023-12-31โ‚น8.61 B-2.7%
2022-12-31โ‚น8.85 B33.93%
2021-12-31โ‚น6.61 B12.78%
2020-12-31โ‚น5.86 B12.96%
2019-12-31โ‚น5.19 B30.93%
2018-12-31โ‚น3.96 B-16.12%
2017-12-31โ‚น4.72 B-11.99%
2016-12-31โ‚น5.37 B1.01%
2015-12-31โ‚น5.31 B670.72%
2014-12-31โ‚น0.68 B-88.74%
2013-12-31โ‚น6.13 B-10.82%
2012-12-31โ‚น6.87 B-12.88%
2011-12-31โ‚น7.88 B0.4%
2010-12-31โ‚น7.85 B-16.44%
2009-12-31โ‚น9.40 B4899.58%
2008-12-31โ‚น0.18 B-63.5%
2007-12-31โ‚น0.51 B22.44%
2006-12-31โ‚น0.42 B83.84%
2005-12-31โ‚น0.22 B192.3%
2004-12-31โ‚น78.32 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Johnson & Johnson
JNJ
โ‚น11.229 T 60,274.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚น7.746 T 41,550.80%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
โ‚น11.185 T 60,040.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚น10.485 T 56,277.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚น8.494 T 45,571.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚น6.317 T 33,868.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Titan Pharmaceuticals
TTNP
โ‚น25.43 M-99.86%๐Ÿ‡บ๐Ÿ‡ธ USA